Fresenius Medical Care AG & Co. (ADR)  

(Public, NYSE:FMS)   Watch this stock  
38.15
-0.54 (-1.40%)
Aug 28 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 37.99 - 38.38
52 week 32.40 - 44.34
Open 38.35
Vol / Avg. 126,599.00/199,903.00
Mkt cap 23.92B
P/E 21.98
Div/yield 0.43/1.13
EPS 1.74
Shares 303.89M
Beta 0.55
Inst. own 4%

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin 7.37% 7.96%
Operating margin 13.03% 14.24%
EBITD margin - 18.50%
Return on average assets 4.92% 5.19%
Return on average equity 10.10% 11.19%
Employees 105,000 -
CDP Score - 82 D

Address

Else-Kroener-Strasse 1
BAD HOMBURG, 61352
Germany
+49-6172-6090 (Phone)
+49-6172-6092301 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Fresenius Medical Care AG & Co. KGaA (FMC AG & CO. KGAA) is a kidney dialysis company. The Company provides dialysis care services related to the dialysis treatment a patient receives with end-stage renal disease (ESRD), as well as other health care services. FMC AG & CO. KGAA also provides dialysis products for the treatment of ESRD, which includes manufacturing and distributing products, such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. The Company's health care services, referred to as care coordination services, include pharmacy services, vascular, cardiovascular and endovascular specialty services, non-dialysis laboratory testing services, physician services, hospitalist and intensivist services, health plan services and urgent care services. The Company also offers a range of dialysis drugs.

Officers and directors

Gerd Krick Chairman of the Supervisory Board
Bio & Compensation  - Reuters
Rice Powell Chairman of the Management Board, Chief Executive Officer
Bio & Compensation  - Reuters
Dieter Schenk Vice Chairman of the Supervisory Board
Bio & Compensation  - Reuters
Michael Brosnan Chief Financial Officer, Member of the Management Board
Bio & Compensation  - Reuters
Oliver Maier Senior Vice President of Investor Relations
Bio & Compensation  - Reuters
Roberto Fuste Member of the Management Board, Chief Executive Officer for Asia-Pacific
Bio & Compensation  - Reuters
Ronald Kuerbitz Member of the Management Board, Chief Executive Officer for North America
Bio & Compensation  - Reuters
Olaf Schermeier Member of the Management Board for Global Research & Development
Bio & Compensation  - Reuters
Kent Wanzek Member of the Management Board, Global Products Manufacturing Operations
Bio & Compensation  - Reuters
Dominik Wehner Member of the Management Board for Europe, Middle East and Africa
Bio & Compensation  - Reuters